Explores the success of the Lauer model in advocating for liver flu infection and liver cancer on the national agenda through collaboration with policymakers.
Covers the historical development of genomics, from Sanger sequencing to high-throughput technologies and cost reductions, highlighting the impact of key players like Craig Venter.
Explores the opportunities and challenges of genomics in biotechnologies and biomedicine, focusing on the human genome, personalized medicine, and the genomics of sudden cardiac death.
